abrdn U.S. Small Cap Equity Fund Institutional Class (GSCIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
40.33
+1.03 (2.62%)
At close: May 12, 2025
13.45% (1Y)
Fund Assets | 519.87M |
Expense Ratio | 0.95% |
Min. Investment | $1,000,000 |
Turnover | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 39.30 |
YTD Return | -0.25% |
1-Year Return | 13.45% |
5-Year Return | 117.55% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 50 |
Inception Date | Jun 29, 2004 |
About GSCIX
GSCIX was founded on 2004-06-29. The Fund's investment strategy focuses on Small-Cap with 1.04% total expense ratio. The minimum amount to invest in Aberdeen Funds: Aberdeen US Small Cap Equity Fund; InstitutionalClass Shares is $1,000,000 on a standard taxable account. Aberdeen Funds: Aberdeen US Small Cap Equity Fund; InstitutionalClass Shares seeks long-term capital appreciation by investing in diversified portfolio of equity securities issued by small capitalization U.S. companies.
Fund Family Aberdeen Fds
Category Small Growth
Performance Rating Above Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol GSCIX
Share Class Institutional Class
Index Russell 2000 TR
Performance
GSCIX had a total return of 13.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.71%.
Top 10 Holdings
28.97% of assetsName | Symbol | Weight |
---|---|---|
ONE Gas, Inc. | OGS | 3.72% |
Casella Waste Systems, Inc. | CWST | 3.11% |
Cash | n/a | 3.04% |
Corcept Therapeutics Incorporated | CORT | 3.00% |
ANI Pharmaceuticals, Inc. | ANIP | 2.80% |
Wintrust Financial Corporation | WTFC | 2.74% |
Enpro Inc. | NPO | 2.70% |
Q2 Holdings, Inc. | QTWO | 2.66% |
Knife River Corporation | KNF | 2.61% |
WSFS Financial Corporation | WSFS | 2.60% |